Downregulating miR-132 for the treatment of lipid related disorders
US10174320B2 · kind B2 · utility
0Cited by
0References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 21, 2015 |
| Grant date | Jan 8, 2019 |
| Priority date | — |
| Expiry date | Sep 21, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/35
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating a lipid-related disorder in a subject in need thereof is disclosed. The method comprises administering to the subject a therapeutically effective amount of a polynucleotide agent which is substantially complementary to a nucleotide sequence of human miR-132, thereby treating the lipid related disorder in the subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.